BioSpace News Archive

Drug Development

Merck & Co., Inc. Release: REPEAT/Viral Suppression In Triple-Class Drug Resistant Patients Maintained After 24 Weeks Of Treatment With MK-0518, An Investigational HIV Integrase Inhibitor, Plus Optimized Background Therapy (OBT)

October 2, 2006
·
6 min read
Deals

I-Flow Corporation Agrees To Sell Its InfuSystem Subsidiary To HAPC, Inc. For An Aggregate Purchase Price Of $140 Million

October 2, 2006
·
4 min read
Deals

Acambis PLC Sells Berna Products, Corporation To Crucell N.V. For $16.5 Million

October 2, 2006
·
4 min read
Drug Development

CellGate, Inc. Initiates Innovative Phase Ib Clinical Study Of Anti-proliferative Agent, CGC-11047, In Advanced Solid Tumors And Lymphomas

October 2, 2006
·
3 min read
Business

Vascular Solutions To Webcast Third Quarter Conference Call Thursday, October 19, 2006 At 3:30pm CST

October 2, 2006
·
1 min read
Drug Development

Human Genome Sciences, Inc. Reports Positive Results Of Phase 1 Clinical Trial Of CCR5 mAb In Patients Infected With HIV-1

October 2, 2006
·
8 min read
Biotech Bay

Onyx Pharmaceuticals, Inc. Secures Equity Financing Commitment

October 2, 2006
·
2 min read
Policy

Adams Respiratory Therapeutics Files Lawsuit Against United Research Laboratories/Mutual Pharmaceutical For Infringement Of Mucinex(R) Patent

October 2, 2006
·
2 min read
Drug Development

Micromet Release: Final Data From Two Phase II Trials Indicate Activity Of Adecatumumab (MT201) In Breast And Prostate Cancer

October 2, 2006
·
12 min read
Business

Edison Pharmaceuticals, Inc. And Institute Of Vision Enter Into Collaboration

October 2, 2006
·
3 min read